U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06851702) titled 'Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients with Hematological Malignancies and Subjected to Treatment with Immune-checkpoint Inhibitors' on Jan. 29.
Brief Summary: Retrospective / prospective observational study of endocrinological adverse events in hematologic patients treated with immunological checkpoint inhibitors
Study Start Date: June, 2025
Study Type: OBSERVATIONAL
Condition:
Hematological Malignancies
Recruitment Status: RECRUITING
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Disclaimer: Curated by HT Syndication....